Companies get U.S. FDA warning letters over diabetes medicines

07/23/2013 | Reuters

The U.S. FDA has warned 15 domestic and international companies to stop selling 20 drugs that it says make false diabetes claims. Some of the drugs are said to be natural products while containing active pharmaceutical ingredients. Others are prescription drugs sold without a prescription, and still others falsely claim to alleviate symptoms, the agency said. FDA compliance officer Howard Sklamberg said that health care fraud with diabetes treatments is a particularly large problem.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA